Only one missense variant namely m.10398A>G referred as rs2853826 polymorphism in MT-ND3 gene was found less frequently in patients (30%) compared to controls (63%) (OR 0.49, 95% CI 0.24–0.97), suggesting a protective effect of this variant in MS. This evidence concerns the gene MT-ND3 and myeloid sarcoma.